300030 阳普医疗
交易中 12-18 10:48:33
资讯
新帖
简况
阳普医疗（300030）披露关于持股5%以上股东一致行动人股份解除冻结的公告，11月24日股价上涨3.27%
证券之星 · 11-24
阳普医疗（300030）披露关于持股5%以上股东一致行动人股份解除冻结的公告，11月24日股价上涨3.27%
阳普医疗：截至2025年9月30日股东数量为28,504户
证券之星 · 11-24
阳普医疗：截至2025年9月30日股东数量为28,504户
阳普医疗（300030）披露召开2025年第一次临时股东会通知，11月12日股价上涨4.13%
证券之星 · 11-12
阳普医疗（300030）披露召开2025年第一次临时股东会通知，11月12日股价上涨4.13%
阳普医疗：公司业务不涉及脑机接口领域
证券之星 · 11-12
阳普医疗：公司业务不涉及脑机接口领域
阳普医疗（300030）2025年三季报简析：净利润同比增长156.55%，盈利能力上升
证券之星 · 10-29
阳普医疗（300030）2025年三季报简析：净利润同比增长156.55%，盈利能力上升
阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%
智通财经 · 10-27
阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%
阳普医疗新注册《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》等2个项目的软件著作权
证券之星 · 08-31
阳普医疗新注册《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》等2个项目的软件著作权
8月27日阳普医疗跌5.74%，华夏智胜先锋股票C基金重仓该股
证券之星 · 08-27
8月27日阳普医疗跌5.74%，华夏智胜先锋股票C基金重仓该股
8月18日阳普医疗涨5.59%，华夏智胜先锋股票C基金重仓该股
证券之星 · 08-18
8月18日阳普医疗涨5.59%，华夏智胜先锋股票C基金重仓该股
阳普医疗（300030）2025年中报简析：净利润增389.4%，盈利能力上升
证券之星 · 08-16
阳普医疗（300030）2025年中报简析：净利润增389.4%，盈利能力上升
阳普医疗最新公告：上半年净利润1526.66万元 同比扭亏
证券之星 · 08-14
阳普医疗最新公告：上半年净利润1526.66万元 同比扭亏
8月14日阳普医疗跌5.86%，华夏智胜先锋股票C基金重仓该股
证券之星 · 08-14
8月14日阳普医疗跌5.86%，华夏智胜先锋股票C基金重仓该股
病毒检测概念盘中拉升，阳普医疗涨4.80%
市场透视 · 08-12
病毒检测概念盘中拉升，阳普医疗涨4.80%
阳普医疗：2025年是公司改善业绩、实现战略突破的关键年份
证券之星 · 08-12
阳普医疗：2025年是公司改善业绩、实现战略突破的关键年份
阳普医疗新注册《阳普医疗全自动血栓弹力图仪温度控制软件V1》等3个项目的软件著作权
证券之星 · 08-11
阳普医疗新注册《阳普医疗全自动血栓弹力图仪温度控制软件V1》等3个项目的软件著作权
8月7日阳普医疗涨8.53%，华夏智胜先锋股票C基金重仓该股
证券之星 · 08-07
8月7日阳普医疗涨8.53%，华夏智胜先锋股票C基金重仓该股
阳普医疗：邓冠华已不再行使经营管理决策权
证券之星 · 07-16
阳普医疗：邓冠华已不再行使经营管理决策权
体外诊断概念盘中拉升，阳普医疗涨16.90%
市场透视 · 07-07
体外诊断概念盘中拉升，阳普医疗涨16.90%
阳普医疗新注册《阳普医疗全自动血栓弹力图仪试剂二维码生成软件V1》项目的软件著作权
证券之星 · 07-07
阳普医疗新注册《阳普医疗全自动血栓弹力图仪试剂二维码生成软件V1》项目的软件著作权
阳普医疗：截至2025年3月31日股东数量为25,909户
证券之星 · 07-02
阳普医疗：截至2025年3月31日股东数量为25,909户
加载更多
公司概况
公司名称：
阳普医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2009-12-25
主营业务：
阳普医疗科技股份有限公司的主营业务是精准医疗、智慧医疗和检验服务。公司的主要产品是智慧实验室产品、IVD(体外诊断)产品、检验服务、信息化产品。公司是从事标本分析前变异控制研究近三十年的高新技术企业，深耕成为国内静脉标本采集领域龙头，在全球行业排名中位列前茅。
发行价格：
25.00
{"stockData":{"symbol":"300030","market":"SZ","secType":"STK","nameCN":"阳普医疗","latestPrice":7.4,"timestamp":1766026113000,"preClose":7.23,"halted":0,"volume":2718800,"delay":0,"changeRate":0.0235,"floatShares":272000000,"shares":309000000,"eps":-0.1661,"marketStatus":"交易中","change":0.17,"latestTime":"12-18 10:48:33","open":7.19,"high":7.43,"low":7.16,"amount":19962700,"amplitude":0.0373,"askPrice":7.4,"askSize":637,"bidPrice":7.39,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-0.1661,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1766028600000},"marketStatusCode":2,"adr":0,"adjPreClose":7.23,"symbolType":"stock","openAndCloseTimeList":[[1766021400000,1766028600000],[1766034000000,1766041200000]],"highLimit":7.95,"lowLimit":6.51,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":309187315,"isCdr":false,"pbRate":3.54,"roa":"--","roe":"3.89%","epsLYR":-0.38,"committee":-0.18763,"marketValue":2288000000,"turnoverRate":0.01,"status":0,"floatMarketCap":2014000000},"requestUrl":"/m/hq/s/300030","defaultTab":"news","newsList":[{"id":"2585446498","title":"阳普医疗（300030）披露关于持股5%以上股东一致行动人股份解除冻结的公告，11月24日股价上涨3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446498","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585446498?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:30","pubTimestamp":1763994626,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，阳普医疗报收于7.9元，较前一交易日上涨3.27%，最新总市值为24.43亿元。阳普医疗科技股份有限公司于近日发布公告，公司持股5%以上股东赵吉庆先生所持有的5,600,000股股份已于2025年11月20日解除冻结，该部分股份占其持股总数的36.60%，占公司总股本的1.81%，原冻结法院为江苏省南京市中级人民法院。本次解除冻结后，赵吉庆及其一致行动人邓冠华合计持股64,494,555股，占公司总股本20.86%，累计被冻结股份数量为0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400036023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300030","BK0146","BK0028"],"gpt_icon":0},{"id":"2585590544","title":"阳普医疗：截至2025年9月30日股东数量为28,504户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585590544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585590544?lang=zh_cn&edition=full","pubTime":"2025-11-24 15:39","pubTimestamp":1763969972,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗(300030)11月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问10月31日的股东人数多少，谢谢阳普医疗回复：尊敬的投资者，您好！公司按照相关规定以及为保证所有投资者平等获悉公司信息，公司在定期报告中面向所有投资者披露了截至报告期末的股东人数。截至2025年9月30日（第三季度期末）股东数量为28,504户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400013303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0251","300030","BK0028"],"gpt_icon":0},{"id":"2582219483","title":"阳普医疗（300030）披露召开2025年第一次临时股东会通知，11月12日股价上涨4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582219483","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582219483?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:32","pubTimestamp":1762939931,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，阳普医疗报收于8.58元，较前一交易日上涨4.13%，最新总市值为26.53亿元。该股当日开盘8.24元，最高8.63元，最低8.22元，成交额达2.32亿元，换手率为10.04%。公司近日发布公告称，阳普医疗科技股份有限公司将于2025年11月27日召开2025年第一次临时股东会，会议由董事会召集，现场会议时间为当日15:30，网络投票时间为9:15至15:00。股权登记日为2025年11月21日。登记时间为2025年11月26日，股东可通过现场或通讯方式登记参会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200028486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0146","BK0028","300030"],"gpt_icon":0},{"id":"2582326737","title":"阳普医疗：公司业务不涉及脑机接口领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2582326737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582326737?lang=zh_cn&edition=full","pubTime":"2025-11-12 16:54","pubTimestamp":1762937649,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗(300030)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问贵公司在脑机接口领域有哪些具体布局，在整个行业大约处于何市场地位？目前是否已经产生收入？阳普医疗回复：尊敬的投资者，您好！公司业务不涉及脑机接口领域，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200026275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030","BK0146","BK0028","BK0251"],"gpt_icon":0},{"id":"2579916345","title":"阳普医疗（300030）2025年三季报简析：净利润同比增长156.55%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579916345","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579916345?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:37","pubTimestamp":1761691027,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期阳普医疗发布2025年三季报。截至本报告期末，公司营业总收入3.49亿元，同比下降17.14%，归母净利润2404.41万元，同比上升156.55%。按单季度数据看，第三季度营业总收入1.18亿元，同比下降7.82%，第三季度归母净利润877.75万元，同比上升123.57%。本报告期阳普医疗盈利能力上升，毛利率同比增幅5.59%，净利率同比增幅163.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900010426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030"],"gpt_icon":0},{"id":"2578615579","title":"阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578615579","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578615579?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:57","pubTimestamp":1761555444,"startTime":"0","endTime":"0","summary":"智通财经APP讯，阳普医疗(300030.SZ)发布2025年三季度报告，该公司前三季度营业收入为3.49亿元，同比减少17.14%。归属于上市公司股东的净利润为2404.41万元，同比增长156.55%。归属于上市公司股东的扣除非经常性损益的净利润为3035.77万元，同比增长325.04%。基本每股收益为0.08元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360393.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"阳普医疗(300030.SZ)发布前三季度业绩，归母净利润2404.41万元，增长156.55%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300030"],"gpt_icon":0},{"id":"2563884365","title":"阳普医疗新注册《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2563884365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563884365?lang=zh_cn&edition=full","pubTime":"2025-08-31 01:46","pubTimestamp":1756575973,"startTime":"0","endTime":"0","summary":"证券之星消息，近日阳普医疗新注册了2个项目的软件著作权，包括《阳普医疗全自动血栓弹力图仪液体吸取控制软件V1》、《阳普医疗全自动血栓弹力图仪主调度软件V1》等。今年以来阳普医疗新注册软件著作权7个。通过天眼查大数据分析，阳普医疗科技股份有限公司共对外投资了17家企业，参与招投标项目384次；财产线索方面有商标信息178条，专利信息183条，著作权信息29条；此外企业还拥有行政许可135个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100000169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0251","BK0028","300030"],"gpt_icon":0},{"id":"2562715555","title":"8月27日阳普医疗跌5.74%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562715555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562715555?lang=zh_cn&edition=full","pubTime":"2025-08-27 16:28","pubTimestamp":1756283335,"startTime":"0","endTime":"0","summary":"证券之星消息，8月27日阳普医疗跌5.74%，收盘报8.21元，换手率8.52%，成交量23.18万手，成交额1.96亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4992，较上一交易日上涨0.33%，近一年上涨58.83%。该公募基金现任基金经理为孙蒙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700033815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","300030","BK0146"],"gpt_icon":0},{"id":"2560977089","title":"8月18日阳普医疗涨5.59%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2560977089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560977089?lang=zh_cn&edition=full","pubTime":"2025-08-18 16:27","pubTimestamp":1755505656,"startTime":"0","endTime":"0","summary":"证券之星消息，8月18日阳普医疗涨5.59%，收盘报9.07元，换手率13.47%，成交量36.66万手，成交额3.34亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4395，较上一交易日上涨1.24%，近一年上涨48.71%。该公募基金现任基金经理为孙蒙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800021695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0251","300030"],"gpt_icon":0},{"id":"2559894906","title":"阳普医疗（300030）2025年中报简析：净利润增389.4%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2559894906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559894906?lang=zh_cn&edition=full","pubTime":"2025-08-16 06:06","pubTimestamp":1755295588,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期阳普医疗发布2025年中报。截至本报告期末，公司营业总收入2.31亿元，同比下降21.22%，归母净利润1526.66万元，同比上升389.4%。按单季度数据看，第二季度营业总收入1.15亿元，同比下降24.07%，第二季度归母净利润745.81万元，同比上升457.8%。本报告期阳普医疗盈利能力上升，毛利率同比增幅3.34%，净利率同比增幅534.76%。短期借款变动幅度为-30.39%,原因:降低贷款规模，自有资金偿还银行借款。财务费用变动幅度为-62.4%,原因:报告期利息费用减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081600004388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030"],"gpt_icon":0},{"id":"2559585956","title":"阳普医疗最新公告：上半年净利润1526.66万元 同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2559585956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559585956?lang=zh_cn&edition=full","pubTime":"2025-08-14 18:10","pubTimestamp":1755166216,"startTime":"0","endTime":"0","summary":"阳普医疗(300030.SZ)发布2025年半年度报告，公司实现营业收入2.31亿元，同比下降21.22%；净利润1526.66万元，同比扭亏。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400035910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030"],"gpt_icon":0},{"id":"2559300889","title":"8月14日阳普医疗跌5.86%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2559300889","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559300889?lang=zh_cn&edition=full","pubTime":"2025-08-14 16:18","pubTimestamp":1755159518,"startTime":"0","endTime":"0","summary":"证券之星消息，8月14日阳普医疗跌5.86%，收盘报8.35元，换手率11.34%，成交量29.48万手，成交额2.51亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4421，较上一交易日上涨0.82%，近一年上涨48.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400029958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","300030","BK0028","BK0251"],"gpt_icon":0},{"id":"2558519692","title":"病毒检测概念盘中拉升，阳普医疗涨4.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558519692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558519692?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:51","pubTimestamp":1754963496,"startTime":"0","endTime":"0","summary":"08月12日，病毒检测概念盘中拉升，截至09点51分，病毒检测概念整体指数上涨0.61%，报1135.980点。从个股上来看，该概念的成分股中，阳普医疗涨4.80%，乐普医疗、复星医药、硕世生物涨幅居前。从资金上来看，截止发稿，病毒检测概念主力净流入为-3.35亿，其中乐普医疗受到资金热捧，主力净流入3970.50万；拉长时间线来看，该板块近20日主力资金净流入-37.98亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095136a482f593&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095136a482f593&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","BK0146","300030","BK0028","BK0239","688399"],"gpt_icon":0},{"id":"2558269182","title":"阳普医疗：2025年是公司改善业绩、实现战略突破的关键年份","url":"https://stock-news.laohu8.com/highlight/detail?id=2558269182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558269182?lang=zh_cn&edition=full","pubTime":"2025-08-12 08:51","pubTimestamp":1754959878,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗08月11日在投资者关系平台上答复投资者关心的问题。主营真空采血系统，说是国内龙头公司，可是连年亏损，还能依靠主营生存吗阳普医疗回复：尊敬的投资者，您好！2025年是公司改善业绩、实现战略突破的关键年份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081200007506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","300030","BK0251","BK0028"],"gpt_icon":0},{"id":"2558684565","title":"阳普医疗新注册《阳普医疗全自动血栓弹力图仪温度控制软件V1》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2558684565","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558684565?lang=zh_cn&edition=full","pubTime":"2025-08-11 01:29","pubTimestamp":1754846948,"startTime":"0","endTime":"0","summary":"证券之星消息，近日阳普医疗新注册了3个项目的软件著作权，包括《阳普医疗全自动血栓弹力图仪温度控制软件V1》、《阳普医疗全自动血栓弹力图仪悬丝控制软件V1》、《阳普医疗全自动血栓弹力图仪样本检测控制软件V1》等。今年以来阳普医疗新注册软件著作权5个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081100000361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030","BK0251","BK0028","BK0146"],"gpt_icon":0},{"id":"2557537110","title":"8月7日阳普医疗涨8.53%，华夏智胜先锋股票C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2557537110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557537110?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:15","pubTimestamp":1754554503,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日阳普医疗涨8.53%创60日新高，收盘报9.29元，换手率24.67%，成交量64.11万手，成交额5.95亿元。重仓阳普医疗的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏智胜先锋股票C。华夏智胜先锋股票C目前规模为9.55亿元，最新净值1.4142，较上一交易日上涨0.56%，近一年上涨45.93%。该公募基金现任基金经理为孙蒙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700025895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030","BK0146","BK0251","BK0028"],"gpt_icon":0},{"id":"2551457541","title":"阳普医疗：邓冠华已不再行使经营管理决策权","url":"https://stock-news.laohu8.com/highlight/detail?id=2551457541","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551457541?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:36","pubTimestamp":1752654975,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗(300030)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问邓冠华作为公司第一大股东，是否已放弃参与公司经营管理的权力？阳普医疗回复：尊敬的投资者，您好！通过协议约定及职务调整，邓冠华先生已不再行使经营管理决策权。公司运营由控股股东委派的管理团队负责，确保经营稳定。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600026071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300030","BK0251","BK0028","BK0146"],"gpt_icon":0},{"id":"2549308265","title":"体外诊断概念盘中拉升，阳普医疗涨16.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549308265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549308265?lang=zh_cn&edition=full","pubTime":"2025-07-07 09:49","pubTimestamp":1751852985,"startTime":"0","endTime":"0","summary":"07月07日，体外诊断概念盘中拉升，截至09点49分，体外诊断概念整体指数上涨1.06%，报1113.940点。从个股上来看，该概念的成分股中，阳普医疗涨16.90%，塞力医疗、迪瑞医疗2只股涨幅超过5%。从资金上来看，截止发稿，体外诊断概念概念主力净流入为-9382.70万，其中浩欧博受到资金热捧，主力净流入1194.74万；拉长时间线来看，该板块近20日主力资金净流入-30.14亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094945979c7355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094945979c7355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0146","BK0028","BK0239","300030","BK0251","688656"],"gpt_icon":0},{"id":"2549500375","title":"阳普医疗新注册《阳普医疗全自动血栓弹力图仪试剂二维码生成软件V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2549500375","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549500375?lang=zh_cn&edition=full","pubTime":"2025-07-07 01:23","pubTimestamp":1751822590,"startTime":"0","endTime":"0","summary":"证券之星消息，近日阳普医疗（300030）新注册了《阳普医疗全自动血栓弹力图仪试剂二维码生成软件V1》项目的软件著作权。今年以来阳普医疗新注册软件著作权1个。结合公司2024年年报财务数据，2024年公司在研发方面投入了3189.9万元，同比减14.98%。通过天眼查大数据分析，阳普医疗科技股份有限公司共对外投资了17家企业，参与招投标项目381次；财产线索方面有商标信息178条，专利信息184条，著作权信息25条；此外企业还拥有行政许可95个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700000303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300030","BK0146","BK0251"],"gpt_icon":0},{"id":"2548855421","title":"阳普医疗：截至2025年3月31日股东数量为25,909户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548855421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548855421?lang=zh_cn&edition=full","pubTime":"2025-07-02 11:36","pubTimestamp":1751427384,"startTime":"0","endTime":"0","summary":"证券之星消息，阳普医疗(300030)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年6月30日，公司股东数是多少？阳普医疗回复：尊敬的投资者：您好！公司按照相关规定以及为保证所有投资者平等获悉公司信息，公司在定期报告中面向所有投资者披露了截至报告期末的股东人数。截至2025年3月31日（第一季度期末）股东数量为25,909户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200014904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0146","BK0028","300030"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766026115689,"stockEarnings":[{"period":"1week","weight":-0.0549},{"period":"1month","weight":-0.1289},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.1386},{"period":"1year","weight":0.0759},{"period":"ytd","weight":0.3098}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"阳普医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"28504人(较上一季度增加16.74%)","perCapita":"9550股","listingDate":"2009-12-25","address":"广东省珠海市香洲区横琴新区环岛东路3000号横琴国际商务中心801-8017室","registeredCapital":"30918万元","survey":" 阳普医疗科技股份有限公司的主营业务是精准医疗、智慧医疗和检验服务。公司的主要产品是智慧实验室产品、IVD(体外诊断)产品、检验服务、信息化产品。公司是从事标本分析前变异控制研究近三十年的高新技术企业，深耕成为国内静脉标本采集领域龙头，在全球行业排名中位列前茅。","listedPrice":25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阳普医疗(300030)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阳普医疗(300030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阳普医疗,300030,阳普医疗股票,阳普医疗股票老虎,阳普医疗股票老虎国际,阳普医疗行情,阳普医疗股票行情,阳普医疗股价,阳普医疗股市,阳普医疗股票价格,阳普医疗股票交易,阳普医疗股票购买,阳普医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阳普医疗(300030)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阳普医疗(300030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}